Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126354823 | 12635482 | 3 | F | 201212 | 20160816 | 20160809 | 20160825 | EXP | CA-HQ SPECIALTY-CA-2016INT000735 | INTERCHEM | 56.00 | YR | F | Y | 0.00000 | 20160825 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126354823 | 12635482 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | 3.5714 MG, (25 MG,1 IN 1 W) | 201749 | 25 | MG | ||||||||
| 126354823 | 12635482 | 2 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 25 MG,1 W | 1032906 | 0 | 25 | MG | |||||||
| 126354823 | 12635482 | 3 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 10 MG, (5 MG,2 IN 1 D) | 0 | 5 | MG | ||||||||
| 126354823 | 12635482 | 4 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | UNK | 0 | ||||||||||
| 126354823 | 12635482 | 5 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | 2.8571 MG, (40 MG,1 IN 2 W) | 0 | 40 | MG | ||||||||
| 126354823 | 12635482 | 6 | SS | RITUXAN | RITUXIMAB | 1 | Unknown | 1 G | 0 | 1 | G | ||||||||
| 126354823 | 12635482 | 7 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 126354823 | 12635482 | 8 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | 0 | ||||||||||
| 126354823 | 12635482 | 9 | SS | ARAVA | LEFLUNOMIDE | 1 | Oral | 20 MG, (20 MG 1 IN 1 D) | 0 | 20 | MG | ||||||||
| 126354823 | 12635482 | 10 | C | GOLD | GOLD | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126354823 | 12635482 | 1 | Rheumatoid arthritis |
| 126354823 | 12635482 | 2 | Rheumatoid arthritis |
| 126354823 | 12635482 | 3 | Rheumatoid arthritis |
| 126354823 | 12635482 | 4 | Rheumatoid arthritis |
| 126354823 | 12635482 | 5 | Rheumatoid arthritis |
| 126354823 | 12635482 | 6 | Rheumatoid arthritis |
| 126354823 | 12635482 | 7 | Rheumatoid arthritis |
| 126354823 | 12635482 | 8 | Rheumatoid arthritis |
| 126354823 | 12635482 | 9 | Rheumatoid arthritis |
| 126354823 | 12635482 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126354823 | 12635482 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126354823 | 12635482 | Abdominal discomfort | |
| 126354823 | 12635482 | Back pain | |
| 126354823 | 12635482 | Blood pressure increased | |
| 126354823 | 12635482 | Drug ineffective | |
| 126354823 | 12635482 | Dysphagia | |
| 126354823 | 12635482 | Femur fracture | |
| 126354823 | 12635482 | Gait disturbance | |
| 126354823 | 12635482 | Haemorrhage | |
| 126354823 | 12635482 | Hypersensitivity | |
| 126354823 | 12635482 | Intervertebral disc degeneration | |
| 126354823 | 12635482 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126354823 | 12635482 | 2 | 20121108 | 0 | ||
| 126354823 | 12635482 | 3 | 20150905 | 0 | ||
| 126354823 | 12635482 | 5 | 20130506 | 20131008 | 0 | |
| 126354823 | 12635482 | 6 | 20131022 | 20140507 | 0 | |
| 126354823 | 12635482 | 8 | 2004 | 0 |